Successful Therapy of Severe Oro-Labial Herpes Simplex With Muco-Adhesive Acyclovir.

Successful Therapy of Severe Oro-Labial Herpes Simplex With Muco-Adhesive Acyclovir. J Drugs Dermatol. 2018 Apr 01;17(4):479-480 Authors: Rosen T Abstract Although muco-adhesive acyclovir 50mg tablets are only approved for the management of recurrent oro-labial HSV-1 infections, their ability to achieve extremely high concentrations in saliva and oral tissues suggests the potential for other uses. In this case, the agent was successfully utilized as a single tablet monotherapy leading to rapid clinical resolution of severe post-operative oro-labial infection. <p><em>J Drugs Dermatol. 2018;17(4):479-480.</em></p>. PMID: 29601626 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/29601626?dopt=Abstract

Source: Journal of Drugs in Dermatology - March 31, 2018 Category: Dermatology Tags: J Drugs Dermatol Source Type: research